We are excited to introduce our #PharmaProductBooster! In our Roland Berger #PharmaWinners study, we discovered that #Pharmaceutical companies frequently face hurdles in maximizing their full product potential. Our booster is designed around a comprehensive, yet highly actionable approach to evaluate and address product #performance issues, delivering tangible results in as little as 7 weeks. Have you encountered obstacles related to: - Pricing and access - Account performance - Product positioning & messaging If so, we are eager to engage with you about our booster program. María Jodra Carrillo, Valerie Czaya, Matthias Bünte, Thilo Kaltenbach, Morris Hosseini, Filip Conic, Michael Baur, Omer Saka, Lennart Boesch, Stephan Fath, Julien Gautier, Dr. Ramya Nair, Tommes Riemer
Marco Bühren’s Post
More Relevant Posts
-
It needs to be mentioned that tangible results mean product performance improvement in financial terms.
We are excited to introduce our #PharmaProductBooster! In our Roland Berger #PharmaWinners study, we discovered that #Pharmaceutical companies frequently face hurdles in maximizing their full product potential. Our booster is designed around a comprehensive, yet highly actionable approach to evaluate and address product #performance issues, delivering tangible results in as little as 7 weeks. Have you encountered obstacles related to: - Pricing and access - Account performance - Product positioning & messaging If so, we are eager to engage with you about our booster program. María Jodra Carrillo, Valerie Czaya, Matthias Bünte, Thilo Kaltenbach, Morris Hosseini, Filip Conic, Michael Baur, Omer Saka, Lennart Boesch, Stephan Fath, Julien Gautier, Dr. Ramya Nair, Tommes Riemer
To view or add a comment, sign in
-
It's crucial to assess how prescribers perceive pharma brands by measuring the stickiness and clarity of a brand's clinical and financial differentiators. MMIT's Shawn Cripps explains a new frontier in brand messaging assessment in this blog. https://ow.ly/4elO50S7Gm7 #Pharma #PharmaCompanies #HealthcareProfessionals #HCPs
To view or add a comment, sign in
-
🔍 𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗯𝗮𝗿𝗿𝗶𝗲𝗿𝘀 𝗶𝗻 𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝗰𝗰𝗲𝘀𝘀: 𝗣𝗮𝗿𝘁 𝟮 ❓ What does good look like in the face of growing regulatory complexities, fierce competition, and pricing pressures? Part 2 of our series highlights the key to success in today’s pharmaceutical industry: • Regulatory resilience: Anticipating and navigating complex regulatory shifts. • Strategic market positioning: Understanding the market landscape for a competitive edge. • Pricing strategy and market access excellence: Balancing patient access with sustainable revenue through agile pricing strategies. Thriving in pharma requires mastering these strategies, driven by the right insights. 🚀 Stay tuned for expert insights from Wayne Speechly and Sahana Ganesh as we continue to explore these challenges in our ongoing series. 💡 #Pharma #Regulatoryresilience #Marketstrategy #Pricingstrategy #Healthcareleadership
To view or add a comment, sign in
-
It's crucial to assess how prescribers perceive pharma brands by measuring the stickiness and clarity of a brand's clinical and financial differentiators. MMIT's Shawn Cripps explains a new frontier in brand messaging assessment in this blog. https://ow.ly/zTFP50S7Gwc #Pharma #PharmaCompanies #HealthcareProfessionals #HCPs
To view or add a comment, sign in
-
Every market is different, even if geographically close! Launch benchmarks can help tremendously. Register and dial in to our upcoming launch webinar with experts from Merck (MSD), BMS, Sanofi and Novartis to learn how to prioritize for launch! #pharmamarketing
Successfully launching a product across EU5 markets is highly dependent on the local context. Launch benchmarks can provide valuable guidance for market-specific priority setting. Learn more on how to set and monitor the right launch priorities in our upcoming webinar. Register here: https://loom.ly/_5YFgu0 #pharma #druglaunch #strategy
To view or add a comment, sign in
-
Join our webinar and find out how to set your priorities right for a successful launch of your drug!
Successfully launching a product across EU5 markets is highly dependent on the local context. Launch benchmarks can provide valuable guidance for market-specific priority setting. Learn more on how to set and monitor the right launch priorities in our upcoming webinar. Register here: https://loom.ly/_5YFgu0 #pharma #druglaunch #strategy
To view or add a comment, sign in
-
It's interesting to see that the local context of markets pharma companies are launching their new products in is also traceable in the perceptions of HCPs in those markets on common launch KPIs such as awareness or product familiarity. At Trilations, we support pharma clients with strategic insights that are data-driven. This includes providing benchmarks of historic succesful launches to compare to when preparing your market entry. Want to learn more? Let's get in touch.
Successfully launching a product across EU5 markets is highly dependent on the local context. Launch benchmarks can provide valuable guidance for market-specific priority setting. Learn more on how to set and monitor the right launch priorities in our upcoming webinar. Register here: https://loom.ly/_5YFgu0 #pharma #druglaunch #strategy
To view or add a comment, sign in
-
Every market is different, even if geographically close! Launch benchmarks can help tremendously. Register and dial in to our upcoming launch webinar with experts from Merck (MSD), BMS, Sanofi and Novartis to learn how to prioritize for launch! (sorry, this will be late night event for Japan and APAC, but we can share the webinar recording with registrants.) Trilations, Trilations Healthcare Strategies
Successfully launching a product across EU5 markets is highly dependent on the local context. Launch benchmarks can provide valuable guidance for market-specific priority setting. Learn more on how to set and monitor the right launch priorities in our upcoming webinar. Register here: https://loom.ly/_5YFgu0 #pharma #druglaunch #strategy
To view or add a comment, sign in
-
The Inflation Reduction Act of 2022 has near and far-reaching implications on the ecosystem of pharmaceutical access and drug commercialization. Watch the replay of eMAX Health’s discussion regarding the Payers’ Perspective on the Inflation Reduction Act of 2022 at www.emaxhealth.net.
To view or add a comment, sign in
-
Excited to announce our participation at the #pharma MARCON event in Berlin next week! 👋 Drop by our booth and let's connect! Plus, don't miss our CCO, Nico Bacharidis, presenting the latest trends in healthcare #tenders and how AI can optimize the entire #tendering lifecycle. 🔝 Learn about the critical role of insights in terms of differentiation and shaping the future of pharmaceutical procurement. we.CONECT - Discover a unique B2B event experience! #tenderinginnovation #pharmaceuticalprocurement #CubeRM #tendermanagement #tenderdata #aiinhealthcare #aidata #pharmainsights #medtechinnovation #dataanalytics #competitiveintelligence #marketintelligence #marketaccess
To view or add a comment, sign in